Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

10 Results

Guidelines and Advice

Surgical Management of Patients with Lymph Node Metastases from Cutaneous Melanoma of the Trunk or Extremities

Status: Current
ID: 8-6
Version: 2

Aug 2018

Guidelines and Advice

Systemic Adjuvant Therapy for Adult Patients at High Risk for Recurrent Melanoma

Status: Current
ID: 8-1
Version: 6

Mar 2024

Guidelines and Advice

Safe Administration of Systemic Cancer Therapy Part 2: Administration of Systemic Treatment and Management of Preventable Adverse Events

Status: In-Review
ID: 12-12-2
Version: 2

Nov 2018

Guidelines and Advice

Systemic therapy for unresectable advanced or metastatic pancreatic and midgut neuroendocrine tumours

Status: Current
ID: GL 2-21
Version: 2

Mar 2024

Guidelines and Advice

Systemic therapy for the treatment of adult patients with lower-risk myelodysplastic syndromes

Status: In-Review
ID: 6-13

Mar 2018

Guidelines and Advice

Safety Considerations for the Implementation of Subcutaneous Rituximab Formulation

Status: Current
Version: 1

Jun 2018

Guidelines and Advice

Self-Management in Cancer: Quality Standards

Status: Current
ID: N/A
Version: 1

Nov 2018

Statistical Reports

Statistiques 2018 sur le cancer en Ontario

Jan 2018

Drug

selinexor

Other Name(s): Xpovio®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Mar 2024

Guidelines and Advice

Sentinel Lymph Node Biopsy in Vulvar Cancer

Status: In-Review
ID: 4-17
Version: 2

Jan 2018